№ lp_2_3_57997
File format: docx
Character count: 125721
File size: 150 KB
Category:
Health Condition/ Disease
Subcategory:
Intervention
Last Updated:
2014-03-11
Keywords:
headache, migraine, attack, migrainous head pain, aura, neurological disorder, nervous system
Evidence:
B, C & D
Grade of Evidence:
B, C & D
Context:
A systematic review and critical analysis of dietary components that are self-reported as triggers for migraines, based on cross-sectional, case-control, experimental, and cohort studies.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2019–2020
Region / country:
Australia
Subject:
Chronic migraine treatment and drug listing
Document type:
Public Summary Document (PSD)
Organization / authority:
Pharmaceutical Benefits Advisory Committee (PBAC), TGA
Drug:
Galcanezumab (Emgality)
Other drugs referenced:
Fremanezumab, Erenumab, Botox
Target population:
Adults with chronic migraine unresponsive to at least three prophylactic migraine medications
Administration form:
Injection 120 mg/1 mL pre-filled pen
Prescription restrictions:
Streamlined listing, treatment by neurologist required, specific clinical criteria for migraine frequency and prior treatment response
Consumer input:
Included 186 individuals, 2 health professionals, 1 organization
Cost analysis:
Cost-minimisation analysis (CMA) versus Botox
Risk sharing arrangement:
Included, with expenditure cap adjustments
Date:
[Date]
Patient:
[Patient’s First and Last Name]
Date of Birth:
[Patient’s Date of Birth]
Insurance Company:
[Insurance Company Name]
Subscriber ID #:
[Insurance Subscriber ID]
Subscriber Group #:
[Insurance Group ID]
Insurance Company Contact:
[Insurance Company Contact]
Insurance Company Address:
[Insurance Company Address]
Insurance Company City, State ZIP:
[Insurance Company City, State ZIP]
Medication:
VYEPTI® (eptinezumab-jjmr) [100 mg/300 mg]
Indication:
Preventive treatment of chronic/episodic migraine
ICD-10 Code:
[ICD-10 code]
Prior Treatments:
[List prior treatments with dates and reasons for discontinuation]
Dose Initiation:
[100 mg/300 mg]
Dose Escalation:
[If applicable, 300 mg]
Treatment Continuation:
[Current VYEPTI dose and response]
Physician:
[Physician’s Name]
Provider Identification Number:
[Provider Identification Number]
Practice Name:
[Name of Practice]
Practice Phone Number:
[Phone Number]
Enclosures:
Original Letter of Medical Necessity, patient clinical/diagnostic notes, relevant lab reports, published clinical references
Year:
2026
Patient Name:
[REDACTED]
Patient DOB:
[REDACTED]
Insurance Company:
[REDACTED]
Policy Number:
[REDACTED]
Group Number:
[REDACTED]
ICD10 Codes:
[REDACTED]
Test Name:
Hemiplegic Migraine Panel
CPT Codes:
81406x1, 81407x1, 81479x1
Laboratory:
GeneDx, Inc.
Laboratory Address:
207 Perry Parkway, Gaithersburg, MD 20877
Laboratory NPI:
1487632998
Laboratory TAXID:
205446298
Laboratory CLIA:
21D0969951
Ordering Provider:
[REDACTED]
Purpose:
Request for insurance coverage for medically necessary genetic testing
Clinical Indications:
Hemiplegic migraine with aura, family and personal medical history, uninformative prior genetic tests
Relevant Genes:
CACNA1A, SCN1A, ATP1A2, PRRT2
Clinical Features:
Aura, hemiplegic attacks, ataxia, intellectual disability, risk of seizures
Inheritance Pattern:
Autosomal dominant for familial hemiplegic migraine
Target Population:
Individuals with hemiplegic migraine symptoms and family history of similar disorders
References:
Albury et al. 2017; Huang et al. 2017; Pelzer et al. 2018; Jen JC 2001/2015; Noebels et al. 2012; Ebrahimi-Fakhari et al. 2015; Riant et al. 2010
Year:
2024
Location:
Tangent Theater, Trinity College Dublin, Ireland
Theme:
Clinical Neurology, Headache Disorders
Document type:
Conference Program
Organizing body:
Trinity College Dublin
Course director:
Dr Anhar Hassan
Speakers:
Prof Anhar Hassan, Ms Helen Cahill, Prof Miriam Galvin, Ms Naomi Thornton, Ms Sharon Moran, Dr Petya Mihaylova, Dr Siobhan Hutchinson, Ms Mary Pilladath, Dr Eddie O’Sullivan, Dr Nicholas Silver, Prof Brian McGuire
Target audience:
Healthcare professionals, neurologists, clinicians
Date:
February 2, 2024
Schedule:
09:00–16:30
Sessions:
Registration, Welcome, Keynote lectures, Panel discussions, Coffee breaks, Lunch, Closing remarks
Context:
Detailed agenda of a professional neurology conference including lectures, discussions, and practical sessions on migraine and other headache disorders
Year:
2023
Region / City:
Global
Topic:
Migraine Treatment and Prophylaxis
Document Type:
Pharmaceutical List
Author:
Not specified
Target Audience:
Healthcare professionals
Period of validity:
Ongoing
Approval Date:
Not specified
Date of modifications:
Not specified
Year:
2023
Region / City:
Unknown
Subject:
Behavioral analysis and intervention plan for individuals with challenging behaviors
Document Type:
Behavioral Report
Author:
Unknown
Target Audience:
Staff involved in the care or treatment of individuals with challenging behaviors
Period of Action:
Ongoing
Approval Date:
Unknown
Date of Changes:
Unknown
Year:
2024
Region / city:
Greater Manchester
Topic:
Hospital delirium management
Document type:
Key document
Organization:
Dementia United
Author:
British Geriatric Society
Target audience:
Healthcare professionals
Effective period:
From January 2024
Approval date:
January 2024
Modification date:
Not specified
Year:
2024
Region / City:
Greater Manchester
Topic:
Delirium management in adults
Document type:
Clinical guidance / key document
Organization:
Dementia United, British Geriatric Society
Target audience:
Healthcare professionals managing adult patients with delirium
Version:
2.0
Date of publication:
January 2024
Patient age group:
Over 18 years
Notes:
For patients not under the influence of drugs or alcohol, clinical judgement required for red flags
Year:
2026
Region / City:
Not specified
Topic:
Programming and Database Management
Document Type:
Educational/Technical Guide
Institution / Organization:
Not specified
Author:
Not specified
Target Audience:
Students and developers learning PL/SQL
Key Concepts:
Cursors, Triggers, Exceptions, Functions, Procedures, SQLCODE, SQLERRM, Virtual Tables, Compilation, Transactions, Sequences, ROWID
Examples Included:
Yes
Usage:
Academic and professional reference
Programming Language:
PL/SQL
Database System:
Oracle
Sponsor:
Riddet Institute, Massey University
Lead Researcher:
Professor David S. Rowlands
Study Site:
Massey University, Albany
Ethics committee ref.:
18248
Year:
2026
Region / city:
Palmerston North, New Zealand
Theme:
Nutritional science, protein turnover, amino acids
Document Type:
Research study participant information sheet
Institution:
Massey University
Target Audience:
Potential participants in clinical trial
Period of validity:
2026
Date of approval:
2026
Date of changes:
N/A
Note:
Year
Topic:
Dietary assessment
Document type:
Survey form
Target audience:
Parents or guardians of children
Contextual description:
A survey form designed for assessing the dietary diversity of children and whether meals were reheated before consumption.
Year:
2022
Region / city:
Baghdad, Iraq
Topic:
Spinal Cord Injury, Dietary Regimen, Educational Intervention
Document type:
Research Study
Organization / institution:
University of Baghdad, College of Nursing
Authors:
Ali Abdulridha Shalash, Ayad Majid Mousa
Target audience:
Healthcare professionals, researchers, educators
Period of validity:
N/A
Approval date:
N/A
Date of changes:
N/A
Year:
2019
Region / city:
Australia, New Zealand
Theme:
Food Safety, Food Additives
Document type:
Assessment Report
Agency:
FSANZ (Food Standards Australia New Zealand)
Author:
FSANZ
Target audience:
Regulatory bodies, industry professionals, food safety experts
Period of validity:
Ongoing
Approval date:
21 March 2019
Date of changes:
None
Topic:
dietary intake frequency
Document type:
survey questionnaire codebook
Population:
adults
Time reference:
past month
Variables:
age, sex, food and beverage consumption frequency
Measurement method:
self-reported frequency categories
Response format:
categorical codes
Data structure:
variable list with attributes and codes
Source type:
health and nutrition survey instrument
Year:
2023
Region / city:
Akure, Nigeria
Topic:
Poultry nutrition, Egg quality, Feed additives
Document type:
Research article
Organization / institution:
Federal University of Technology, Akure
Author:
Omotoso O. B., Samuel D. A., Oso T. S., Olamide E. I., Akande O. A., Okhankhuele O. T., Ogunwande I. O., Oludahunsi O. F.
Target audience:
Researchers, poultry farmers, academics
Effective period:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Note:
Year
Year:
2023
Region / city:
Livingstone, Zambia; Lusaka, Zambia; Twickenham, London, UK; Nashville, TN, USA
Subject:
Hypertension, dietary salt, inflammation
Document type:
Research study
Organization / institution:
Mulungushi University, University of Zambia, St. Mary’s University, Vanderbilt University Medical Center
Author:
Sepiso K. Masenga, Leta Pilic, Benson M. Hamooya, Selestine Nzala, Geoffrey Kwenda, Douglas C. Heimburger, Wilbroad Mutale, John R. Koethe, Annet Kirabo, Sody M. Munsaka
Target audience:
Researchers, healthcare professionals
Period of validity:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Year:
2023
Region / City:
Islamabad, Pakistan
Subject:
Pesticides Residue Analysis
Document Type:
Research Article
Organization:
Ecotoxicology Research Program, IPEP, NARC
Author:
Syeda Nazish Ali, Nazia Rafique, Shazia Akhtar, Touqeer Taj, Farrakh Mehboob
Target Audience:
Researchers, Agricultural Scientists, Environmental Health Experts
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year:
2023
Region / city:
Ireland
Theme:
Dietary intake in cystic fibrosis
Document type:
Research article
Organization / institution:
Not specified
Author:
Not specified
Target audience:
Researchers, healthcare professionals
Period of validity:
Not applicable
Date of approval:
Not specified
Date of changes:
Not specified
Note:
Context description